New drug trial aims to tame tough blood cancers
Disease control
Recruiting now
This early-stage trial tests a new drug called UBX-303061 in people with certain blood cancers (B-cell malignancies) that have returned or stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose. About 94 adults will take pa…
Phase: PHASE1 • Sponsor: Ubix Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC